Suppr超能文献

2019冠状病毒病治疗的现状:一篇观点综述。

Current status of COVID-19 treatment: An opinion review.

作者信息

Di Franco Sveva, Alfieri Aniello, Petrou Stephen, Damiani Giovanni, Passavanti Maria Beatrice, Pace Maria Caterina, Leone Sebastiano, Fiore Marco

机构信息

Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples 80138, Italy.

Department of Emergency Medicine, Good Samaritan Hospital Medical Center, New York, NY 11795, United States.

出版信息

World J Virol. 2020 Sep 25;9(3):27-37. doi: 10.5501/wjv.v9.i3.27.

Abstract

The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has garnered the attention of scientists worldwide in the search for an effective treatment while also focusing on vaccine development. Several drugs have been used for the management of coronavirus disease 2019 (COVID-19), which has affected many hospitals and health centers worldwide. Statistically significant results are lacking on the effectiveness of the experimented drugs in reducing COVID-19 morbidity or mortality, as there are very few published randomized clinical trials. Despite this, the literature offers some material for study and reflection. This opinion review attempts to address three burning questions on COVID-19 treatment options. (1) What kind of studies are currently published or ongoing in the treatment of patients with COVID-19? (2) What drugs are currently described in the literature as options of treatment for patients affected by the infection? And (3) Are there specific clinical manifestations related to COVID-19 that can be treated with a customized and targeted therapy? By answering these questions, we wish to create a summary of current COVID-19 treatments and the anti-COVID-19 treatments proposed in the recent clinical trials developed in the last 3 mo, and to describe examples of clinical manifestations of the SARS-CoV-2 infection with a cause-related treatment.

摘要

大流行的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染在寻求有效治疗方法的同时,也引起了全球科学家对疫苗研发的关注。几种药物已被用于治疗2019冠状病毒病(COVID-19),这种疾病已经影响了全球许多医院和医疗中心。由于很少有已发表的随机临床试验,目前尚缺乏关于实验性药物在降低COVID-19发病率或死亡率方面有效性的具有统计学意义的结果。尽管如此,文献还是提供了一些可供研究和思考的素材。这篇观点综述试图回答关于COVID-19治疗方案的三个紧迫问题。(1)目前在治疗COVID-19患者方面发表了哪些研究或正在进行哪些研究?(2)目前文献中描述了哪些药物可作为受该感染影响患者的治疗选择?以及(3)是否存在与COVID-19相关的特定临床表现,可以通过定制的靶向治疗进行治疗?通过回答这些问题,我们希望对当前的COVID-19治疗方法以及最近3个月内开展的临床试验中提出的抗COVID-19治疗方法进行总结,并描述与病因相关治疗的SARS-CoV-2感染临床表现实例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ffd/7520874/264391ec22b0/WJV-9-27-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验